Jennifer L. Davis, CEO in Health Care, sold Procter & Gamble (PG) shares on the open market three times in the last year, for a total of $2 million. Her most recent sale occurred on October 2, 2025. These sales rank 3,494th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. Davis made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 3, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | M | Restricted Stock Units | 60 | $0.00 | 965.5700 | 2,454,400,000 | 5.89% | 0.00% |
| Nov. 17, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 34 | $0.00 | 262.6603 | 2,454,400,000 | 14.85% | 0.00% |
| Dec. 3, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | F | Common Stock | 60 | $144.35 | 77,303.3815 | 2,454,400,000 | 0.08% | 0.00% |
| Dec. 3, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | M | Common Stock | 60 | $144.35 | 77,363.8115 | 2,454,400,000 | 0.08% | 0.00% |
| Oct. 2, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | S | Common Stock | 3227 | $152.23 | 77,299.2355 | 2,454,400,000 | 4.01% | 0.00% |
| Oct. 1, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Stock Option (Right to Buy) | 68869 | $0.00 | 68,869.0000 | 2,454,400,000 | 9999.99% | 0.00% |
| Aug. 19, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | S | Common Stock | 8596 | $157.27 | 80,392.6154 | 2,454,400,000 | 9.66% | 0.00% |
| Aug. 18, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Common Stock | 21518 | $0.00 | 88,988.6154 | 2,454,400,000 | 31.89% | 0.00% |
| Aug. 15, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 25 | $0.00 | 228.7027 | 2,454,400,000 | 12.24% | 0.00% |
| May 15, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 24 | $0.00 | 203.7584 | 2,462,100,000 | 13.27% | 0.00% |
| July 14, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Series A Preferred Stock | 1 | $0.00 | 4,351.7444 | 2,454,400,000 | 0.01% | 0.00% |
| Aug. 7, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 1026 | $0.00 | 1,026.0000 | 2,454,400,000 | 9999.99% | 0.00% |
| May 9, 2025 | AbbVie Inc. | $ABBV | Davis Jennifer L. | Not found | A | Common Stock, $0.01 par value | 1203 | $0.00 | 2,525.0000 | 1,773,000,000 | 91.00% | 0.00% |
| Feb. 18, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 22 | $0.00 | 179.8861 | 2,462,100,000 | 14.05% | 0.00% |
| April 29, 2025 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | S | Common Stock | 1000 | $161.38 | 66,803.3290 | 2,462,100,000 | 1.47% | 0.00% |
| Dec. 19, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | F | Common Stock | 46 | $169.79 | 67,528.5737 | 2,471,900,000 | 0.07% | 0.00% |
| Nov. 15, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 22 | $0.00 | 157.7264 | 2,471,900,000 | 15.94% | 0.00% |
| Dec. 19, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | M | Restricted Stock Units | 46 | $0.00 | 736.7300 | 2,471,900,000 | 5.91% | 0.00% |
| Dec. 19, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | M | Common Stock | 46 | $169.79 | 67,574.8437 | 2,471,900,000 | 0.07% | 0.00% |
| Oct. 1, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Stock Option (Right to Buy) | 56554 | $0.00 | 56,554.0000 | 2,471,900,000 | 9999.99% | 0.00% |
| Oct. 2, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | S | Common Stock | 4447 | $171.65 | 67,370.1553 | 2,471,900,000 | 6.19% | 0.00% |
| Aug. 15, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 17 | $0.00 | 136.0431 | 2,471,900,000 | 14.24% | 0.00% |
| Aug. 20, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | S | Common Stock | 6223 | $169.22 | 71,817.1553 | 2,471,900,000 | 7.97% | 0.00% |
| Aug. 19, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Common Stock | 15971 | $0.00 | 77,935.3069 | 2,471,900,000 | 25.77% | 0.00% |
| Aug. 1, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 783 | $0.00 | 783.0000 | 2,471,900,000 | 9999.99% | 0.00% |
| July 16, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Series A Preferred Stock | 104 | $0.00 | 4,351.1121 | 2,471,900,000 | 2.45% | 0.00% |
| May 15, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 17 | $0.00 | 119.0806 | 2,483,900,000 | 16.76% | 0.00% |
| Feb. 15, 2024 | PROCTER & GAMBLE Co | $PG | Davis Jennifer L. | CEO - Health Care | A | Restricted Stock Units | 17 | $0.00 | 101.9852 | 2,483,900,000 | 19.73% | 0.00% |
| May 3, 2024 | AbbVie Inc. | $ABBV | Davis Jennifer L. | Not found | A | Common Stock, $0.01 par value | 1322 | $0.00 | 1,322.0000 | 1,773,000,000 | 9999.99% | 0.00% |